C20ORF11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.810200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.556400E-01
Normal-vs-Stage2
5.911800E-01
Normal-vs-Stage3
4.047600E-01
Normal-vs-Stage4
2.668200E-01
Stage1-vs-Stage2
4.534800E-01
Stage1-vs-Stage3
2.146200E-01
Stage1-vs-Stage4
3.267600E-01
Stage2-vs-Stage3
1.089040E-01
Stage2-vs-Stage4
7.357400E-01
Stage3-vs-Stage4
1.102440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.608000E-01
Normal-vs-AfricanAmerican
7.370400E-01
Normal-vs-Asian
8.185600E-01
Caucasian-vs-AfricanAmerican
4.631800E-02
Caucasian-vs-Asian
5.362000E-01
AfricanAmerican-vs-Asian
8.189200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.171000E-01
Normal-vs-Female
6.803000E-01
Male-vs-Female
2.052400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.415600E-01
Normal-vs-Age(41-60Yrs)
4.148600E-01
Normal-vs-Age(61-80Yrs)
7.000000E-01
Normal-vs-Age(81-100Yrs)
6.354400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.784600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.841400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.040600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.927900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.347400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.730600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.380800E-01
Normal-vs-Daily Drinker
3.979000E-01
Normal-vs-Weekly Drinker
8.421000E-01
Normal-vs-Occasional Drinker
1.872200E-01
Normal-vs-Social Drinker
5.653000E-01
Non Drinker-vs-Daily Drinker
1.230210E-01
Non Drinker-vs-Weekly Drinker
8.282800E-01
Non Drinker-vs-Occasional Drinker
4.821700E-02
Non Drinker-vs-Social Drinker
3.850800E-01
Daily Drinker-vs-Weekly Drinker
7.913900E-02
Daily Drinker-vs-Occasional Drinker
7.697400E-01
Daily Drinker-vs-Social Drinker
6.532400E-01
Weekly Drinker-vs-Occasional Drinker
2.397600E-02
Weekly Drinker-vs-Social Drinker
3.204600E-01
Occasional Drinker-vs-Social Drinker
4.437600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.851000E-01
Normal-vs-Grade 2
7.816200E-01
Normal-vs-Grade 3
2.250000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.859600E-01
Grade 1-vs-Grade 3
1.120040E-01
Grade 1-vs-Grade 4
4.851000E-01
Grade 2-vs-Grade 3
2.338400E-02
Grade 2-vs-Grade 4
7.816200E-01
Grade 3-vs-Grade 4
2.250000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.795000E-01
Normal-vs-NonDiabetic
4.832600E-01
Diabetic-vs-NonDiabetic
6.185900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.843600E-01
Normal-vs-NoPancreatitis
5.965600E-01
Pancreatitis-vs-NoPancreatitis
3.313200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.002400E-01
Normal-vs-N1
6.391400E-01
N0-vs-N1
6.111000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.550010E-01
Normal-vs-TP53-NonMutant
6.246000E-01
TP53-Mutant-vs-TP53-NonMutant
4.338000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
